Legal Status Overview
Gray AreaSouth Carolina has no state statute, administrative regulation, or Board of Pharmacy rule that names peptides or 'research chemicals' as a distinct legal category. Instead, South Carolina licenses and disciplines pharmacies and pharmacists under the state Pharmacy Practice Act, and compounding pharmacies operating in the state must follow the same federal FDA 503A/503B framework that applies nationwide. As a practical matter this means unapproved peptides sold as 'research use only' fall into a gray zone: they are not scheduled controlled substances under South Carolina law, but they also are not FDA-approved drugs, so selling or dispensing them for human use without a valid prescription and appropriate compounding authority is not clearly lawful.
Key Points
- South Carolina has not enacted any statute or Board of Pharmacy regulation that specifically names peptides, BPC-157, TB-500, or 'research chemicals' as a distinct regulated category, based on a review of South Carolina's pharmacy statutes and Board of Pharmacy materials. [3]
- The South Carolina Board of Pharmacy, operating under the South Carolina Department of Labor, Licensing and Regulation, licenses and disciplines pharmacies and pharmacists in the state, including any compounding pharmacy that would prepare a peptide product for a patient. [2]
- Compounding pharmacies in South Carolina, like those in every other state, must operate within the federal FDA framework set out in Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act, which govern what substances may lawfully be compounded and under what conditions. [1]
- No South Carolina-specific Board of Pharmacy bulletin, consent order, or enforcement action naming peptide products (BPC-157, TB-500, or compounded GLP-1 drugs) was found during this research, so any enforcement in South Carolina would currently rely on general federal FDA and state pharmacy-licensing authority rather than a peptide-specific state rule. (No reliable source found for this point — flagged as unverified rather than stated as fact.)
- A person cannot lawfully bring in, buy, or use research-labeled peptides such as BPC-157 or TB-500 for personal human use in South Carolina without a valid prescription from a licensed practitioner, because these substances are not FDA-approved drugs and 'research use only' labeling is intended to exclude human consumption. (No reliable source found for this point — flagged as unverified rather than stated as fact.)
- GLP-1 medicines such as semaglutide and tirzepatide are legal, prescription-only drugs in South Carolina when dispensed as the FDA-approved brand products (e.g., Ozempic, Wegovy, Mounjaro, Zepbound) through a licensed prescriber and pharmacy, subject to the same state pharmacy licensing rules as any other prescription drug. [2]
- No South Carolina bill specifically addressing peptides, research chemicals, or compounded GLP-1 drugs was identified in recent legislative sessions during this research, meaning any future change to peptide legality in South Carolina would most likely come from federal FDA action rather than state law. (No reliable source found for this point — flagged as unverified rather than stated as fact.)
Peptide-by-peptide status in South Carolina
| BPC-157 | BPC-157 is not an FDA-approved drug and has no South Carolina-specific statute addressing it, so its sale and use for human injection in South Carolina exists in a legal gray area governed only by general federal drug and compounding law rather than a state-specific ban or permission. [1] |
|---|---|
| Semaglutide / Tirzepatide (GLP-1 class) | Semaglutide and tirzepatide are legal, prescription-only medicines in South Carolina when supplied as FDA-approved products (Ozempic, Wegovy, Mounjaro, Zepbound) through a licensed prescriber, while non-FDA-approved compounded or 'research' versions fall outside that approved framework and are not clearly authorized under South Carolina or federal law. [1] |
| TB-500 | TB-500 has no South Carolina-specific statute or Board of Pharmacy rule addressing it, so like BPC-157 it is legally unaddressed at the state level and is not an FDA-approved drug for human use in South Carolina. |
| Human Growth Hormone (HGH/Somatropin) | Human growth hormone is a prescription-only drug in South Carolina, and no South Carolina statute expands on the federal rule that distributing or possessing HGH for any use other than a condition diagnosed by a licensed physician is a federal offense. |
Sources
Last researched: 2026-09-09
Frequently asked questions
Can I buy peptides like BPC-157 in South Carolina without a prescription?
No reliable South Carolina-specific rule permits over-the-counter sale of peptides like BPC-157 for human use; because BPC-157 is not FDA-approved, buying it labeled 'for research use only' and using it on yourself falls into an unregulated gray area rather than a clearly legal retail transaction.
Is it legal to get compounded semaglutide or tirzepatide from a South Carolina pharmacy?
It depends on the pharmacy's compounding authority: a South Carolina compounding pharmacy may only prepare a compounded GLP-1 product under the conditions FDA allows in Sections 503A or 503B of the Food, Drug, and Cosmetic Act, and outside of a recognized drug shortage those conditions are narrow. [1]
Can a telehealth provider legally prescribe peptides to someone in South Carolina?
A telehealth provider can prescribe an FDA-approved drug to a South Carolina patient only if licensed to prescribe in South Carolina and following state telehealth and pharmacy rules, but no South Carolina rule specifically authorizes telehealth prescribing of unapproved 'research peptides' such as BPC-157 or TB-500.
What are the penalties for selling unapproved peptides in South Carolina?
No South Carolina statute sets a peptide-specific penalty, so enforcement would rely on general state pharmacy-licensing violations or federal FDA action against unapproved new drugs and misbranding, and no South Carolina enforcement action specifically targeting peptide sellers was identified in this research.
Does South Carolina treat peptides as controlled substances like anabolic steroids?
No, South Carolina's controlled substances schedules do not list peptides such as BPC-157 or TB-500 the way they list anabolic steroids, so peptides are not scheduled drugs in South Carolina even though they remain unapproved by the FDA for human use.